Aidoc vs HeartFlow
Aidoc and HeartFlow both compete in radiology, but answer different questions. Aidoc is our pick for acute-care triage: Most-deployed acute-care triage AI in US hospitals (1,000+ sites). HeartFlow earns the reimbursable CCTA AI slot: Non-invasive CCTA-derived FFR, reimbursable since CPT 75577 (Jan 2026). The right choice depends on whether your priority is acute-care triage or reimbursable ccta ai.
- Radiology
- 02
- October 20, 2026
Aidoc
by Aidoc · founded 2016
Clinical AI platform (aiOS) with FDA-cleared triage, notification and quantification algorithms for radiology and neurovascular care.
- Private offer only. No trial is stated.
- FDA 510(k) (multiple) / EU MDR 2017/745 / ISO 13485:2016
HeartFlow
by HeartFlow · founded 2007
Coronary CT angiogram analysis: CT-derived fractional flow reserve (FFRct), plaque analysis and a CCTA reading aid.
- No public list price. The 10-K describes revenue as pay-per-use.
- FDA De Novo / FDA 510(k) / CE Mark (FFRct Analysis, 2011)
How Aidoc and HeartFlow compare
Pricing, compliance, and integrations sourced from vendor documentation. Verified October 20, 2026.
| Spec | Aidoc | HeartFlow |
|---|---|---|
| Pricing | Private offer only. No trial is stated. | No public list price. The 10-K describes revenue as pay-per-use. |
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | 2016 | 2007 |
| HQ | IL | US |
| Best for | Best for acute-care triage | Best reimbursable CCTA AI |
Scroll horizontally to see both columns.
When to pick each one
Best for acute-care triage
Most-deployed acute-care triage AI in US hospitals (1,000+ sites).
- 31+ FDA clearances across stroke, PE, ICH, C-spine
- Foundation model CARE1 across modalities
Best reimbursable CCTA AI
Non-invasive CCTA-derived FFR, reimbursable since CPT 75577 (Jan 2026).
- Most clinical-evidence-backed CCTA AI
- IPO filed 2026
- Eliminates invasive angiography for many patients
Other head-to-heads worth reading
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.